{"count": 49, "results": [{"_id": "38022184", "pmid": 38022184, "pmcid": "PMC10676215", "title": "A Case of Angiotensin-Converting Enzyme (ACE) Inhibitor-Induced Small Bowel Angioedema", "journal": "Cureus", "authors": ["Pirzada S", "Raza B", "Mankani AA", "Naveed B"], "date": "2023-10-26T00:00:00Z", "doi": "10.7759/cureus.47739", "meta_date_publication": "2023 Oct", "meta_volume": "15", "meta_issue": "10", "meta_pages": "e47739", "score": 50253.33, "text_hl": "We describe a rare case of a 58-year-old female with a history of @<m>DISEASE_Diabetes_Mellitus_Type_2</m> @DISEASE_MESH:D003924 @@@type 2 diabetes@@@ and @DISEASE_Hypertension @DISEASE_MESH:D006973 @@@hypertension@@@ taking @<m>CHEMICAL_Lisinopril</m> @CHEMICAL_MESH:D017706 @@@lisinopril@@@ for the past three years and presented with recurrent episodes of @DISEASE_Abdominal_Pain @DISEASE_MESH:D015746 @@@abdominal pain@@@, @DISEASE_Nausea @DISEASE_MESH:D009325 @@@nausea@@@, and @DISEASE_Vomiting @DISEASE_MESH:D014839 @@@vomiting@@@ around the same time she started taking the drug. ", "citations": {"NLM": "Pirzada S, Raza B, Mankani AA, Naveed B. A Case of Angiotensin-Converting Enzyme (ACE) Inhibitor-Induced Small Bowel Angioedema Cureus. 2023 Oct;15(10):e47739. PMID: 38022184", "BibTeX": "@article{38022184, title={A Case of Angiotensin-Converting Enzyme (ACE) Inhibitor-Induced Small Bowel Angioedema}, author={Pirzada S and Raza B and Mankani AA and Naveed B}, journal={Cureus}, volume={15}, number={10}, pages={e47739}}"}}, {"_id": "34282598", "pmid": 34282598, "title": "Effect of Lisinopril and Verapamil on Angiopoietin 2 and Endostatin in Hypertensive Diabetic Patients with Nephropathy: A Randomized Trial.", "journal": "Horm Metab Res", "authors": ["Salem M", "Sallam AM", "Abdel-Aleem E", "El-Mesallamy HO"], "date": "2021-07-01T00:00:00Z", "doi": "10.1055/a-1517-6643", "meta_date_publication": "2021 Jul", "meta_volume": "53", "meta_issue": "7", "meta_pages": "470-477", "score": 50252.28, "text_hl": "We performed a randomized-controlled trial of @<m>CHEMICAL_Lisinopril</m> @CHEMICAL_MESH:D017706 @@@lisinopril@@@ alone (an ACEI) or in combination with @CHEMICAL_Verapamil @CHEMICAL_MESH:D014700 @@@verapamil@@@ (a CCB) as a therapy for @DISEASE_Diabetic_Nephropathies @DISEASE_MESH:D003928 @@@DN@@@ in @<m>DISEASE_Diabetes_Mellitus_Type_2</m> @DISEASE_MESH:D003924 @@@type 2 diabetes mellitus@@@ (@<m>DISEASE_Diabetes_Mellitus_Type_2</m> @DISEASE_MESH:D003924 @@@T2DM@@@) @SPECIES_9606 @@@patients@@@ with @DISEASE_Hypertension @DISEASE_MESH:D006973 @@@hypertension@@@ (@DISEASE_Hypertension @DISEASE_MESH:D006973 @@@HTN@@@) and urinary @GENE_ALB @GENE_213 @@@albumin@@@ @CHEMICAL_Creatinine @CHEMICAL_MESH:D003404 @@@creatinine@@@ ratio (UACR) (30-300 mg/g) also to evaluate their effect on UACR, the angiogenic proteins: @GENE_ANGPT2 @GENE_285 @@@Angiopoietin 2@@@ (@GENE_ANGPT2 @GENE_285 @@@Ang-2@@@) and @GENE_COL18A1 @GENE_80781 @@@Endostatin@@@ (@GENE_COL18A1 @GENE_80781 @@@EST@@@). ", "citations": {"NLM": "Salem M, Sallam AM, Abdel-Aleem E, El-Mesallamy HO. Effect of Lisinopril and Verapamil on Angiopoietin 2 and Endostatin in Hypertensive Diabetic Patients with Nephropathy: A Randomized Trial. Horm Metab Res. 2021 Jul;53(7):470-477. PMID: 34282598", "BibTeX": "@article{34282598, title={Effect of Lisinopril and Verapamil on Angiopoietin 2 and Endostatin in Hypertensive Diabetic Patients with Nephropathy: A Randomized Trial.}, author={Salem M and Sallam AM and Abdel-Aleem E and El-Mesallamy HO}, journal={Horm Metab Res}, volume={53}, number={7}, pages={470-477}}"}}, {"_id": "34057517", "pmid": 34057517, "title": "Antidiabetic Potential of Stem Bark Extract of Enantia chlorantha and Lack of Modulation of Its Therapeutic Efficacy in Diabetic Rats Co-Administered with Lisinopril.", "journal": "Acta Chim Slov", "authors": ["Ibrahim LB", "Idowu PF", "Mose SOA", "Alabi MA", "Ajani EO"], "date": "2021-03-01T00:00:00Z", "meta_date_publication": "2021 Mar", "meta_volume": "68", "meta_issue": "1", "meta_pages": "127", "score": 50250.38, "text_hl": "This study validates the antidiabetic efficacy of Enantia chlorantha stem bark and the possible therapeutic implications of the co-administration of @<m>CHEMICAL_Lisinopril</m> @CHEMICAL_MESH:D017706 @@@lisinopril@@@ and E. chlorantha in @<m>DISEASE_Diabetes_Mellitus_Type_2</m> @DISEASE_MESH:D003924 @@@type 2 diabetic@@@ @SPECIES_10116 @@@rats@@@. ", "citations": {"NLM": "Ibrahim LB, Idowu PF, Mose SOA, Alabi MA, Ajani EO. Antidiabetic Potential of Stem Bark Extract of Enantia chlorantha and Lack of Modulation of Its Therapeutic Efficacy in Diabetic Rats Co-Administered with Lisinopril. Acta Chim Slov. 2021 Mar;68(1):127. PMID: 34057517", "BibTeX": "@article{34057517, title={Antidiabetic Potential of Stem Bark Extract of Enantia chlorantha and Lack of Modulation of Its Therapeutic Efficacy in Diabetic Rats Co-Administered with Lisinopril.}, author={Ibrahim LB and Idowu PF and Mose SOA and Alabi MA and Ajani EO}, journal={Acta Chim Slov}, volume={68}, number={1}, pages={127}}"}}, {"_id": "34180715", "pmid": 34180715, "title": "Therapeutic effects of lisinopril and empagliflozin in a mouse model of hypertension-accelerated diabetic kidney disease.", "journal": "Am J Physiol Renal Physiol", "authors": ["Østergaard MV", "Secher T", "Christensen M", "Salinas CG", "Roostalu U", "Skytte JL", "Rune I", "Hansen HH", "Jelsing J", "Vrang N", "Fink LN"], "date": "2021-08-01T00:00:00Z", "doi": "10.1152/ajprenal.00154.2021", "meta_date_publication": "2021 Aug 1", "meta_volume": "321", "meta_issue": "2", "meta_pages": "F149-F161", "score": 50247.68, "text_hl": "Therapeutic effects of @<m>CHEMICAL_Lisinopril</m> @CHEMICAL_MESH:D017706 @@@lisinopril@@@ and @CHEMICAL_empagliflozin @CHEMICAL_MESH:C570240 @@@empagliflozin@@@ in a @SPECIES_10090 @@@mouse@@@ model of @DISEASE_Hypertension @DISEASE_MESH:D006973 @@@hypertension@@@-accelerated @DISEASE_Diabetic_Nephropathies @DISEASE_MESH:D003928 @@@diabetic kidney disease@@@.", "citations": {"NLM": "Østergaard MV, Secher T, Christensen M, Salinas CG, Roostalu U, Skytte JL, Rune I, Hansen HH, Jelsing J, Vrang N, Fink LN. Therapeutic effects of lisinopril and empagliflozin in a mouse model of hypertension-accelerated diabetic kidney disease. Am J Physiol Renal Physiol. 2021 Aug 1;321(2):F149-F161. PMID: 34180715", "BibTeX": "@article{34180715, title={Therapeutic effects of lisinopril and empagliflozin in a mouse model of hypertension-accelerated diabetic kidney disease.}, author={Østergaard MV and Secher T and Christensen M and Salinas CG and Roostalu U and Skytte JL and Rune I and Hansen HH and Jelsing J and Vrang N and Fink LN}, journal={Am J Physiol Renal Physiol}, volume={321}, number={2}, pages={F149-F161}}"}}, {"_id": "9279969", "pmid": 9279969, "title": "Lisinopril improves endothelial dysfunction in hypertensive NIDDM subjects with diabetic nephropathy.", "journal": "Scand J Clin Lab Invest", "authors": ["Nielsen FS", "Rossing P", "Gall MA", "Smidt UM", "Chen JW", "Sato A", "Parving HH"], "date": "1997-08-01T00:00:00Z", "doi": "10.3109/00365519709084591", "meta_date_publication": "1997 Aug", "meta_volume": "57", "meta_issue": "5", "meta_pages": "427-34", "score": 50065.445, "text_hl": "@<m>CHEMICAL_Lisinopril</m> @CHEMICAL_MESH:D017706 @@@Lisinopril@@@ improves @DISEASE_Vascular_Diseases @DISEASE_MESH:D014652 @@@endothelial dysfunction@@@ in @<m>DISEASE_Diabetes_Mellitus_Type_2</m> @DISEASE_MESH:D003924 @@@hypertensive NIDDM@@@ subjects with @DISEASE_Diabetic_Nephropathies @DISEASE_MESH:D003928 @@@diabetic nephropathy@@@.", "citations": {"NLM": "Nielsen FS, Rossing P, Gall MA, Smidt UM, Chen JW, Sato A, Parving HH. Lisinopril improves endothelial dysfunction in hypertensive NIDDM subjects with diabetic nephropathy. Scand J Clin Lab Invest. 1997 Aug;57(5):427-34. PMID: 9279969", "BibTeX": "@article{9279969, title={Lisinopril improves endothelial dysfunction in hypertensive NIDDM subjects with diabetic nephropathy.}, author={Nielsen FS and Rossing P and Gall MA and Smidt UM and Chen JW and Sato A and Parving HH}, journal={Scand J Clin Lab Invest}, volume={57}, number={5}, pages={427-34}}"}}, {"_id": "9179532", "pmid": 9179532, "title": "Lisinopril. A review of its pharmacology and use in the management of the complications of diabetes mellitus.", "journal": "Drugs", "authors": ["Goa KL", "Haria M", "Wilde MI"], "date": "1997-06-01T00:00:00Z", "doi": "10.2165/00003495-199753060-00010", "meta_date_publication": "1997 Jun", "meta_volume": "53", "meta_issue": "6", "meta_pages": "1081-105", "score": 50064.473, "text_hl": "In summary, @<m>CHEMICAL_Lisinopril</m> @CHEMICAL_MESH:D017706 @@@lisinopril@@@ lowers blood pressure and produces a renoprotective effect in @SPECIES_9606 @@@patients@@@ with @DISEASE_Diabetes_Mellitus_Type_1 @DISEASE_MESH:D003922 @@@IDDM@@@ and @<m>DISEASE_Diabetes_Mellitus_Type_2</m> @DISEASE_MESH:D003924 @@@NIDDM@@@ without detriment to glycaemic control or @CHEMICAL_Lipids @CHEMICAL_MESH:D008055 @@@lipid@@@ profiles. ", "citations": {"NLM": "Goa KL, Haria M, Wilde MI. Lisinopril. A review of its pharmacology and use in the management of the complications of diabetes mellitus. Drugs. 1997 Jun;53(6):1081-105. PMID: 9179532", "BibTeX": "@article{9179532, title={Lisinopril. A review of its pharmacology and use in the management of the complications of diabetes mellitus.}, author={Goa KL and Haria M and Wilde MI}, journal={Drugs}, volume={53}, number={6}, pages={1081-105}}"}}, {"_id": "8070610", "pmid": 8070610, "title": "Impact of lisinopril and atenolol on kidney function in hypertensive NIDDM subjects with diabetic nephropathy.", "journal": "Diabetes", "authors": ["Nielsen FS", "Rossing P", "Gall MA", "Skøtt P", "Smidt UM", "Parving HH"], "date": "1994-09-01T00:00:00Z", "doi": "10.2337/diab.43.9.1108", "meta_date_publication": "1994 Sep", "meta_volume": "43", "meta_issue": "9", "meta_pages": "1108-13", "score": 50064.13, "text_hl": "Impact of @<m>CHEMICAL_Lisinopril</m> @CHEMICAL_MESH:D017706 @@@lisinopril@@@ and @CHEMICAL_Atenolol @CHEMICAL_MESH:D001262 @@@atenolol@@@ on kidney function in @<m>DISEASE_Diabetes_Mellitus_Type_2</m> @DISEASE_MESH:D003924 @@@hypertensive NIDDM@@@ subjects with @DISEASE_Diabetic_Nephropathies @DISEASE_MESH:D003928 @@@diabetic nephropathy@@@.", "citations": {"NLM": "Nielsen FS, Rossing P, Gall MA, Skøtt P, Smidt UM, Parving HH. Impact of lisinopril and atenolol on kidney function in hypertensive NIDDM subjects with diabetic nephropathy. Diabetes. 1994 Sep;43(9):1108-13. PMID: 8070610", "BibTeX": "@article{8070610, title={Impact of lisinopril and atenolol on kidney function in hypertensive NIDDM subjects with diabetic nephropathy.}, author={Nielsen FS and Rossing P and Gall MA and Skøtt P and Smidt UM and Parving HH}, journal={Diabetes}, volume={43}, number={9}, pages={1108-13}}"}}, {"_id": "22540049", "pmid": 22540049, "pmcid": "PMC3335894", "title": "Effect of Eplerenone, a Selective Aldosterone Blocker, on the Development of Diabetic Nephropathy in Type 2 Diabetic Rats", "journal": "Diabetes Metab J", "authors": ["Ahn JH", "Hong HC", "Cho MJ", "Kim YJ", "Choi HY", "Eun CR", "Yang SJ", "Yoo HJ", "Kim HY", "Seo JA", "Kim SG", "Choi KM", "Baik SH", "Choi DS", "Kim NH"], "date": "2012-04-01T00:00:00Z", "doi": "10.4093/dmj.2012.36.2.128", "meta_date_publication": "2012 Apr", "meta_volume": "36", "meta_issue": "2", "meta_pages": "128-35", "score": 50061.934, "text_hl": "@CHEMICAL_Eplerenone @CHEMICAL_MESH:D000077545 @@@Eplerenone@@@ and @<m>CHEMICAL_Lisinopril</m> @CHEMICAL_MESH:D017706 @@@lisinopril@@@ combination showed additional benefits on @<m>DISEASE_Diabetes_Mellitus_Type_2</m> @DISEASE_MESH:D003924 @@@type 2 diabetic nephropathy@@@ compared to monotherapy of each drug.", "citations": {"NLM": "Ahn JH, Hong HC, Cho MJ, Kim YJ, Choi HY, Eun CR, Yang SJ, Yoo HJ, Kim HY, Seo JA, Kim SG, Choi KM, Baik SH, Choi DS, Kim NH. Effect of Eplerenone, a Selective Aldosterone Blocker, on the Development of Diabetic Nephropathy in Type 2 Diabetic Rats Diabetes Metab J. 2012 Apr;36(2):128-35. PMID: 22540049", "BibTeX": "@article{22540049, title={Effect of Eplerenone, a Selective Aldosterone Blocker, on the Development of Diabetic Nephropathy in Type 2 Diabetic Rats}, author={Ahn JH and Hong HC and Cho MJ and Kim YJ and Choi HY and Eun CR and Yang SJ and Yoo HJ and Kim HY and Seo JA and Kim SG and Choi KM and Baik SH and Choi DS and Kim NH}, journal={Diabetes Metab J}, volume={36}, number={2}, pages={128-35}}"}}, {"_id": "16091636", "pmid": 16091636, "title": "[Antioxidative defense in patients with acute coronary syndrome and concomitant type 2 diabetes and its modification by lisinopril].", "journal": "Kardiologiia", "authors": ["Kratnov AE", "Popov SA", "Kratnov AA", "Dem'iankova IuO"], "date": "2005-01-01T00:00:00Z", "meta_date_publication": "2005", "meta_volume": "45", "meta_issue": "8", "meta_pages": "23-7", "score": 50061.105, "text_hl": "[Antioxidative defense in @SPECIES_9606 @@@patients@@@ with @DISEASE_Acute_Coronary_Syndrome @DISEASE_MESH:D054058 @@@acute coronary syndrome@@@ and concomitant @<m>DISEASE_Diabetes_Mellitus_Type_2</m> @DISEASE_MESH:D003924 @@@type 2 diabetes@@@ and its modification by @<m>CHEMICAL_Lisinopril</m> @CHEMICAL_MESH:D017706 @@@lisinopril@@@].", "citations": {"NLM": "Kratnov AE, Popov SA, Kratnov AA, Dem'iankova IuO. [Antioxidative defense in patients with acute coronary syndrome and concomitant type 2 diabetes and its modification by lisinopril]. Kardiologiia. 2005;45(8):23-7. PMID: 16091636", "BibTeX": "@article{16091636, title={[Antioxidative defense in patients with acute coronary syndrome and concomitant type 2 diabetes and its modification by lisinopril].}, author={Kratnov AE and Popov SA and Kratnov AA and Dem'iankova IuO}, journal={Kardiologiia}, volume={45}, number={8}, pages={23-7}}"}}, {"_id": "11358940", "pmid": 11358940, "title": "Effect of antihypertensive therapy on renal artery structure in type 2 diabetic rats with hypertension.", "journal": "Hypertension", "authors": ["Reddi AS", "Nimmagadda VR", "Arora R"], "date": "2001-05-01T00:00:00Z", "doi": "10.1161/01.hyp.37.5.1273", "meta_date_publication": "2001 May", "meta_volume": "37", "meta_issue": "5", "meta_pages": "1273-8", "score": 50060.91, "text_hl": "We have previously demonstrated that antihypertensive treatment with @CHEMICAL_Doxazosin @CHEMICAL_MESH:D017292 @@@doxazosin@@@ (@CHEMICAL_Doxazosin @CHEMICAL_MESH:D017292 @@@DZN@@@), an alpha-adrenergic blocker, and @<m>CHEMICAL_Lisinopril</m> @CHEMICAL_MESH:D017706 @@@lisinopril@@@ (@<m>CHEMICAL_Lisinopril</m> @CHEMICAL_MESH:D017706 @@@LIS@@@), an ACE inhibitor, reverse @DISEASE_Kidney_Diseases @DISEASE_MESH:D007674 @@@glomerular sclerosis@@@ in corpulent spontaneously @DISEASE_Hypertension @DISEASE_MESH:D006973 @@@hypertensive@@@ @SPECIES_10116 @@@rats@@@ with @<m>DISEASE_Diabetes_Mellitus_Type_2</m> @DISEASE_MESH:D003924 @@@type 2 diabetes@@@. ", "citations": {"NLM": "Reddi AS, Nimmagadda VR, Arora R. Effect of antihypertensive therapy on renal artery structure in type 2 diabetic rats with hypertension. Hypertension. 2001 May;37(5):1273-8. PMID: 11358940", "BibTeX": "@article{11358940, title={Effect of antihypertensive therapy on renal artery structure in type 2 diabetic rats with hypertension.}, author={Reddi AS and Nimmagadda VR and Arora R}, journal={Hypertension}, volume={37}, number={5}, pages={1273-8}}"}}]}